Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $53.31M.
ENTERPRISE VALUE (EV)
$53.31M
BioAge Labs Inc.
Market Cap
$237.22M
Enterprise Value (EV)
$53.31M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| BioAge Labs Inc. (BIOA) | $237.22M | $53.31M |
| High Tide Inc. (HITI)vs › | $237.69M | $292.15M |
| MacroGenics, Inc. (MGNX)vs › | $235.50M | $156.69M |
| CAMP4 Therapeutics Corporation (CAMP)vs › | $240.97M | $156.22M |
| Akebia Therapeutics, Inc. (AKBA)vs › | $240.98M | $139.39M |
| InflaRx N.V. (IFRX)vs › | $241.56M | $75.17M |
| Galectin Therapeutics Inc. (GALT)vs › | $242.35M | $366.79M |
| Biodesix, Inc. (BDSX)vs › | $231.59M | $273.39M |
| Lifecore Biomedical, Inc. (LFCR)vs › | $243.62M | N/A |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $246.67M | $237.79M |
Market Cap
$237.22M
Total Debt
$4.98M
Cash
$188.89M
Enterprise Value
$53.31M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
